INFLUENZA A
Clinical trials for INFLUENZA A explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA A trials appear
Sign up with your email to follow new studies for INFLUENZA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug AVM0703 tested for Life-Threatening lung failure
Disease control Not yet recruitingThis early-stage study tests a single dose of a new drug called AVM0703 in 16 adults with severe breathing failure (ARDS) caused by COVID-19 or the flu. The main goal is to check if the drug is safe and how the body processes it. Participants are randomly assigned to receive the …
Matched conditions: INFLUENZA A
Phase: PHASE1 • Sponsor: AVM Biotechnology Inc • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New At-Home test could detect flu and COVID in minutes
Diagnosis Not yet recruitingThis study will test a new at-home rapid test that checks for flu A, flu B, and COVID-19 using a nasal swab. About 200 people with symptoms will use the test themselves, and their results will be compared to standard lab PCR tests. The goal is to see if the test is accurate and e…
Matched conditions: INFLUENZA A
Phase: NA • Sponsor: CorDx, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
Could a single At-Home swab detect COVID, flu, and RSV?
Diagnosis Not yet recruitingThis study will test a new at-home diagnostic test that aims to detect five respiratory viruses—COVID-19, influenza A and B, RSV, and rhinovirus—from a single nose swab. About 2,000 people with cold or flu symptoms will provide samples in simulated home environments. The test's a…
Matched conditions: INFLUENZA A
Phase: NA • Sponsor: Aptitude Medical Systems • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
Could a single pill shorten the flu? new trial aims to find out
Symptom relief Not yet recruitingThis phase 3 trial tests whether a single dose of baloxavir helps non-hospitalized adults with mild-to-moderate influenza recover faster compared to a placebo. About 264 participants will be enrolled within 5 days of symptoms and tracked until they feel fully recovered. The study…
Matched conditions: INFLUENZA A
Phase: PHASE3 • Sponsor: Unity Health Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New flu pill for teens shows promise in Late-Stage trial
Symptom relief Not yet recruitingThis study tests a new flu medicine called onradivir in teenagers aged 12 to 17 with uncomplicated influenza A. About 150 teens will receive either the drug or a placebo for 5 days. Researchers will track how fast flu symptoms like fever and body aches go away, and check for side…
Matched conditions: INFLUENZA A
Phase: PHASE3 • Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC